Drug supply shortage in Nigeria during COVID-19: efforts and challenges

The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of the drug supply is imported creating a huge supply–demand disparity particularly in times lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Faiva, Edward, Hashim, Hashim Talib, Ramadhan, Mustafa Ahmed, Musa, Shingin Kovona, Bchara, John, Tuama, Yahya Dheyaa, Adebisi, Yusuff Adebayo, Kadhim, Mustafa Hayder, Essar, Mohammad Yasir, Ahmad, Shoaib, Lucero-Prisno, Don Eliseo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820524/
https://www.ncbi.nlm.nih.gov/pubmed/33482871
http://dx.doi.org/10.1186/s40545-021-00302-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820524/
https://www.ncbi.nlm.nih.gov/pubmed/33482871
http://dx.doi.org/10.1186/s40545-021-00302-1

Ejemplares similares